ABOS - Acumen Pharmaceuticals - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

ABOS is currently covered by 6 analysts with an average price target of $11.84. This is a potential upside of $8.31 (235.41%) from yesterday's end of day stock price of $3.53.

Acumen Pharmaceuticals's activity chart (see below) currently has 6 price targets and 20 ratings on display. The stock rating distribution of ABOS is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for ABOS is $15, Lowest price target is $13, average price target is $11.84.

Most recent stock forecast was given by ANDREW FEIN from HC WAINWRIGHT on 27-Mar-2024. First documented stock forecast 26-Jul-2021.

Currently out of the existing stock ratings of ABOS, 15 are a BUY (100%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

15

$11.11 (285.60%)

15

20 days ago

0/6 (0%)

$10.9 (265.85%)

Buy

13

$9.11 (234.19%)

13

8 months 7 days ago

0/5 (0%)

$6.22 (91.74%)

Buy

15

$11.11 (285.60%)

27

8 months 7 days ago

0/2 (0%)

$8.22 (121.24%)

Buy

14

$10.11 (259.90%)

16

8 months 27 days ago

0/3 (0%)

$6.69 (91.52%)

Buy

13

$9.11 (234.19%)

13

8 months 30 days ago

0/2 (0%)

$3.28 (33.74%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ABOS (Acumen Pharmaceuticals) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on ABOS (Acumen Pharmaceuticals) with a proven track record?

GEOFF MEACHAM

Which analyst has the current lower performing score on ABOS (Acumen Pharmaceuticals) with a proven track record?

PETE STAVROPOULOS

Which analyst has the most public recommendations on ABOS (Acumen Pharmaceuticals)?

Geoff Meacham works at BAML and has 9 price targets and 10 ratings on ABOS

Which analyst is the currently most bullish on ABOS (Acumen Pharmaceuticals)?

Thomas Shrader with highest potential upside - $18.11

Which analyst is the currently most reserved on ABOS (Acumen Pharmaceuticals)?

Judah Frommer with lowest potential downside - $9.11

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?